Analyst Moves: PFE, VZ, MU - Presented by: The Aol. On Network

This morning, Leerink Swann increased its price target on shares of Pfizer (PFE) to $28.50 as international sales of Lyrica could boost earnings at the pharmaceutical giant. In the report, Leerink increased its EPS estimates and maintained its market perform rating.

Related Videos

Most Popular Videos

Latest Videos